2015 Transfusion Diagnostics Market: Strategic Assessments of Current and Emerging Competitors

Name: 2015 Transfusion Diagnostics Market: Strategic Assessments of Current and Emerging Competitors
Brand: Venture Planning Group
SKU: 2A292C9C7F9EN
Price: 1960.00 USD
Availability: InStock

October 2015 | 50 pages | ID: 2A292C9C7F9EN
Venture Planning Group

US$ 1,960.00 ~~US$ 2,450.00~~ -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

Abstracts
Contents

This new report from VPGMarketResearch.com provides extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. The assessments include:

Sales
Product portfolios
Marketing tactics
Technological know-how
New products in R&D
Collaborative arrangements
Business strategies

Contains 50 pages

Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Grifols
Hologic/Gen-Probe
Immucor
Ortho-Clinical Diagnostic
Proteome Sciences
Quest
Quidel
Roche
Siemens
Tecan
Thermo Fisher/Life Technologies

More Publications

2015 Strategic Assessments of Current and Emerging Blood Typing, Grouping and NAT Screening Market Players US$ 2,800.00 July 2015 225 pages

2016-2020 Blood Typing, Grouping and Infectious Disease NAT Screening Market: Strategic Assessments of Current and Emerging Competitors US$ 2,800.00 March 2016 225 pages

2015 Strategic Assessments of Current and Emerging Transfusion Diagnostics Market Players US$ 1,960.00 July 2015 50 pages

2015 Strategic Assessments of Current and Emerging Cancer Diagnostics Market Players US$ 2,000.00 July 2015 80 pages

2015 Cancer Diagnostics Market: Strategic Assessments of Current and Emerging Competitors US$ 2,000.00 October 2015 80 pages

2015 Transfusion Diagnostics Market: Strategic Assessments of Current and Emerging Competitors

More Publications

Need Help?

Ask a Question

Market Reports